Anti-anginal and anti-ischaemic effects of the If current inhibitor ivabradine versus atenolol in stable angina. A 4-month randomised, double-blind, multicenter trial

被引：9

作者：

Tardif, JC

Ford, I

Tendera, M

Fox, K

机构：

[1] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada

[2] Slaska Akad Medyczna, Katowice, Poland

[3] Royal Brompton Hosp, London SW3 6LY, England

来源：

EUROPEAN HEART JOURNAL | 2003年 / 24卷

关键词：

D O I：

10.1016/S0195-668X(03)93719-5

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：20 / 20

页数：1

共 20 条

[1] Anti-anginal and anti-ischaemic effects of the If current inhibitor ivabradine in patients with stable angina pectoris receiving beta-blockers. A 4-month randomised, double-blind, multicenter trial
Tardif, J. -C.
Ponikowski, P.
Kahan, T.
EUROPEAN HEART JOURNAL, 2008, 29 : 386 - 387
[2] Anti-anginal and anti-ischaemic effects of the If current inhibitor ivabradine in patients with stable angina pectoris receiving standard doses of beta-blockers. A 4-month randomised, double-blind, multicenter trial
Tardif, J. C.
Ponikowski, P.
Kahan, T.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2008, 22 : 96 - 96
[3] Anti-anginal and anti-ischemic effects of the if current inhibitor ivabradine versus atenolol in stable angina
Tardif, JC
Ford, I
Tendera, M
Fox, K
Bourassa, MG
CIRCULATION, 2003, 108 (17) : 590 - 590
[4] Anti-anginal and anti-ischaemic efficacy of ivabradine - A selective and specific sinus node if current inhibitor - Compared to atenolol in elderly patients with chronic stable angina
Fox, KM
Tardif, JC
Ford, I
Tendera, M
HEART, 2005, 91 : A69 - A69
[5] ANTI-ISCHAEMIC AND ANTI-ANGINAL ACTIVITY OF ATENOLOL, NIFEDIPINE AND THEIR COMBINATION IN STABLE, CHRONIC EFFORT ANGINA
LAI, C
ONNIS, E
PIRISI, R
ORANI, E
DELOGU, G
CHERCHI, A
DRUGS UNDER EXPERIMENTAL AND CLINICAL RESEARCH, 1988, 14 (11) : 699 - 705
[6] Omapatrilat: novel vasopeptidase inhibitor with anti-ischaemic and anti-anginal activity in a placebo-controlled trial in stable, effort-induced angina pectoris
Lawrence, JH
Ivleva, AI
Chaitman, BR
Shlyakhto, E
Ujda, M
Lenis, J
Toth, C
Stieber, D
Reisin, L
Pangerl, A
EUROPEAN HEART JOURNAL, 2001, 22 : 291 - 291
[7] Antianginal and antiischaemic effects of the If current inhibitor ivabradine compared to amiodipine as monotherapies in patients with chronic stable angina. Randomised, controlled, double-blind trial
Ruzyllo, W
Ford, IF
Tendera, MT
Fox, KF
EUROPEAN HEART JOURNAL, 2004, 25 : 138 - 138
[8] Long-term safety and antianginal efficacy of the If current inhibitor ivabradine in patients with chronic stable angina. A one-year randomised, double-blind, multicentre trial
Lopez-Bescos, L
Fillpova, S
Martos, R
EUROPEAN HEART JOURNAL, 2004, 25 : 138 - 138
[9] ANTI-ANGINAL EFFECTS OF EMPAGLIFLOZIN IN PATIENTS WITH TYPE 2 DIABETIC AND REFRACTORY ANGINA; A RANDOMIZED, DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL (EMPT-ANGINA TRIAL)
Mansouri, P.
Mansouri, M.
Khosravi, A.
ATHEROSCLEROSIS, 2023, 379
[10] Antianginal and antiischemic effects of ivabradine, an If inhibitor, in stable angina -: A randomized, double-blind, multicentered, placebo-controlled trial
Borer, JS
Fox, K
Jaillon, P
Lerebours, G
CIRCULATION, 2003, 107 (06) : 817 - 823

← 1 2 →